DNAprint Genomics (DNAG)

[stakddek]

If the Biofrontera deal had proceeded earlier we'd have a new board member. The math looks very favorable for DNAP in acquiring less for even less? All in all, things are happening. A capable pipeline is growing. Devolopment strategies from drug inception to final testing are being put in place. We also share in Biofrontera existing pipeline.

All we need now is to put a foot in genetic cosmetics and use the resources in this global conglamorate to market a product formulated for the consumers particular genes, even at a broad level. For a more personalized approach, your - cream - lotion - hair conditioner - sun block - tanning aid - etc, formulated for your more specific genotype at an additional charge.

What do we need? Revenues. How do we get them? Sell something. (Not shares). Is cosmetics out of left field for DNAG to consider? -- We did consider a company in the past. Couldn't hurt with the right marketing. "DNA-Por-Vou"?

I'd rather we returned some money to the company by selling an honest quality product than diluting our shared ownership of the DNAG that remains.

let's keep the doors open and our real concerns going, but do something about revenues to reduce the dilution that is required for these pipeline expansions.

Stakddek